BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11843219)

  • 41. Cidofovir approved.
    PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature.
    Florin HJ; Snoeck R; Van Cleynenbreugel B; Albersen M
    Antiviral Res; 2018 Oct; 158():238-243. PubMed ID: 30153444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cidofovir.
    Bowers M
    BETA; 1998 Jul; ():41-2. PubMed ID: 11365563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
    Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
    J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.
    Cundy KC; Petty BG; Flaherty J; Fisher PE; Polis MA; Wachsman M; Lietman PS; Lalezari JP; Hitchcock MJ; Jaffe HS
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1247-52. PubMed ID: 7574510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
    Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW
    J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of periungual warts with topical cidofovir.
    Padilla España L; Del Boz J; Fernández Morano T; Arenas-Villafranca J; de Troya M
    Dermatol Ther; 2014; 27(6):337-42. PubMed ID: 25081902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical cidofovir for erythroplasia of Queyrat of the glans penis.
    Calista D
    Br J Dermatol; 2002 Aug; 147(2):399-400. PubMed ID: 12174131
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient.
    Schliefer K; Gümbel HO; Rockstroh JK; Spengler U
    Clin Infect Dis; 1999 Sep; 29(3):684-5. PubMed ID: 10530469
    [No Abstract]   [Full Text] [Related]  

  • 51. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical cidofovir for molluscum contagiosum in children.
    Zabawski EJ; Cockerell CJ
    Pediatr Dermatol; 1999; 16(5):414-5. PubMed ID: 10627225
    [No Abstract]   [Full Text] [Related]  

  • 53. Topical cidofovir for severe molluscum contagiosum.
    Davies EG; Thrasher A; Lacey K; Harper J
    Lancet; 1999 Jun; 353(9169):2042. PubMed ID: 10376628
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
    Rahhal FM; Arevalo JF; Chavez de la Paz E; Munguia D; Azen SP; Freeman WR
    Ann Intern Med; 1996 Jul; 125(2):98-103. PubMed ID: 8678386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
    Kottke MD; Parker SR
    J Am Acad Dermatol; 2006 Sep; 55(3):533-6. PubMed ID: 16908370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of adenoviral conjunctivitis with topical cidofovir.
    Gordon YJ; Naesens L; DeClercq E; Maudgal PC; Veckeneer M
    Cornea; 1996 Sep; 15(5):546. PubMed ID: 8862935
    [No Abstract]   [Full Text] [Related]  

  • 59. New developments in the treatment of CMV retinitis.
    Freeman WR
    Ophthalmology; 1996 Jul; 103(7):999-1000. PubMed ID: 8684813
    [No Abstract]   [Full Text] [Related]  

  • 60. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.